首页> 外文期刊>Haematologica >Detection of alpha-thalassemia in beta-thalassemia carriers and prevention of Hb Bart's hydrops fetalis through prenatal screening | Haematologica
【24h】

Detection of alpha-thalassemia in beta-thalassemia carriers and prevention of Hb Bart's hydrops fetalis through prenatal screening | Haematologica

机译:通过产前筛查检测β-地中海贫血携带者中的α-地中海贫血并预防胎儿Hb Bart胎儿水肿|血液学

获取原文
           

摘要

The aim of this study was to detect alpha-thalassemia in beta-thalassemia carriers during prenatal screening. During a 12-year prenatal screening program, a total of 158 couples (3.2%) were diagnosed to be the discordant alpha- and beta-thalassemia carriers. Of the 158 beta-thalassemia partners, seven (4.4%) were found to have co-inheritance of alpha0-thalassemia, and three (1.9%) found to have co-inheritance of alpha(+)-thalassemia. Three pregnancies affected with Hb Bart's hydrops fetalis were terminated in the 158 couples. The results showed that molecular analysis must be used for accurate diagnosis of double heterozygotes in couples presumed to be discordant for alpha- and beta-thalassemia on hematologic testing.
机译:这项研究的目的是在产前筛查中检测β地中海贫血携带者中的α地中海贫血。在为期12年的产前筛查计划中,总共有158对夫妇(3.2%)被诊断为不一致的α和β地中海贫血携带者。在158个β地中海贫血伴侣中,发现7个(4.4%)具有α0地中海贫血的共同遗传性,三个(1.9%)被发现具有α(+)地中海贫血的共同遗传性。在158对夫妇中,三例受Hb Bart胎儿积水影响的怀孕终止。结果表明,分子分析必须用于准确诊断在血液学检查中被认为与α地中海贫血和β地中海贫血不一致的夫妇中的双重杂合子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号